Retrophin, Inc.. (RTRX) NASDAQ
$24.25 0 (0.00%)
Market Cap: $1.24B
As of 11/18/20 04:00 PM EST. Market closed.
Retrophin, Inc.. (RTRX)
NASDAQ
$24.25
0 (0.00%)
Market Cap: $1.24B
As of 11/18/20 04:00 PM EST. Market closed.
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, ... read more
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Eric Dube
Full Time Employees
221
CEO Compensation (Base)
$593,333
CEO Compensation (Total)
$4.60M
Sector
Health Technology
Industry
Biotechnology
CEO
Eric Dube
Full Time Employees
221
CEO Compensation (Base)
$593,333
CEO Compensation (Total)
$4.60M
Address
3611 Valley Centre Drive, CA, San Diego, 92130.
PRICE CHART FOR RETROPHIN, INC.
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$8.98 - $24.96
Volume
378,991
Avg. Volume (30 days)
295,781
Market Cap
$1.24B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,051,800
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$8.98 - $24.96
Volume
378,991
Avg. Volume (30 days)
295,781
Market Cap
$1.24B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,051,800
Open in: 
Open in:
INSIDER TRANSACTIONS FOR RETROPHIN, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 57,436 | Feb 02, 2023, 07:11 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 60,036 | Feb 02, 2023, 07:08 PM |
| Heerma Peter | Chief Commercial Officer | Feb 01, 2023 | Sale | $21.75 | 1,779 | 38,697 | 82,069 | Feb 02, 2023, 07:04 PM |
| Cline Christopher R. | Chief Financial Officer | Feb 01, 2023 | Sale | $21.75 | 1,588 | 34,542 | 51,533 | Feb 02, 2023, 07:02 PM |
| Dube Eric M | Chief Executive Officer | Feb 01, 2023 | Sale | $22.25 | 8,196 | 182,361 | 237,150 | Feb 02, 2023, 06:58 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Feb 02, 2023 | Sale | $22.42 | 360 | 8,071 | 42,805 | Feb 02, 2023, 06:53 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Feb 01, 2023 | Sale | $21.75 | 1,671 | 36,348 | 43,165 | Feb 02, 2023, 06:53 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Jan 25, 2023 | Sale | $21.63 | 192 | 4,153 | 34,836 | Jan 26, 2023, 04:05 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Jan 24, 2023 | Sale | $21.90 | 905 | 19,823 | 35,028 | Jan 26, 2023, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 42,376 | Jan 26, 2023, 04:05 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 39,776 | Jan 26, 2023, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 24, 2023 | Sale | $21.50 | 6,442 | 138,503 | 147,846 | Jan 26, 2023, 04:05 PM |
| Cline Christopher R. | Chief Financial Officer | Jan 24, 2023 | Sale | $21.90 | 852 | 18,663 | 32,871 | Jan 26, 2023, 04:05 PM |
| Heerma Peter | Chief Commercial Officer | Jan 24, 2023 | Sale | $21.90 | 1,550 | 33,952 | 63,598 | Jan 26, 2023, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2023 | Sale | $20.75 | 5,625 | 116,719 | 154,288 | Jan 06, 2023, 04:05 PM |
| Inrig Jula | Chief Medical Officer | Jan 05, 2023 | Sale | $20.75 | 442 | 9,172 | 17,507 | Jan 06, 2023, 04:05 PM |
| Inrig Jula | Chief Medical Officer | Jan 04, 2023 | Sale | $20.75 | 2,051 | 42,558 | 17,949 | Jan 06, 2023, 04:05 PM |
| Heerma Peter | Chief Commercial Officer | Oct 04, 2022 | Sale | $25.68 | 3,042 | 78,119 | 65,148 | Oct 06, 2022, 08:10 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Sep 13, 2022 | Sale | $28.00 | 349 | 9,772 | 35,933 | Sep 15, 2022, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 11, 2022 | Sale | $21.71 | 1,563 | 33,940 | 44,485 | May 12, 2022, 08:49 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 12, 2022 | Sale | $21.51 | 1,050 | 22,584 | 41,838 | May 12, 2022, 08:47 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 10, 2022 | Sale | $21.51 | 900 | 19,359 | 42,888 | May 12, 2022, 08:47 PM |
| Clague Laura | Chief Financial Officer | May 11, 2022 | Sale | $21.51 | 1,375 | 29,576 | 35,655 | May 12, 2022, 08:45 PM |
| Clague Laura | Chief Financial Officer | May 10, 2022 | Sale | $21.51 | 825 | 17,746 | 37,030 | May 12, 2022, 08:45 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2022 | Sale | $21.51 | 436 | 9,378 | 36,178 | May 12, 2022, 08:44 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2022 | Sale | $21.92 | 445 | 9,756 | 35,733 | May 12, 2022, 08:44 PM |
| ASELAGE STEVE | Director | May 11, 2022 | Sale | $21.92 | 2,575 | 56,457 | 146,919 | May 12, 2022, 08:35 PM |
| Dube Eric M | Chief Executive Officer | Feb 10, 2022 | Sale | $27.84 | 4,832 | 134,523 | 159,913 | Feb 11, 2022, 04:05 PM |
| Calvin Sandra | VP, Corp Controller and CAO | Jan 31, 2022 | Sale | $26.51 | 798 | 21,152 | 36,614 | Feb 02, 2022, 04:22 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 31, 2022 | Sale | $27.40 | 1,350 | 36,990 | 43,788 | Feb 02, 2022, 04:20 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 45,235 | Feb 02, 2022, 04:19 PM |
| Heerma Peter | Chief Commercial Officer | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 67,297 | Feb 02, 2022, 04:18 PM |
| Clague Laura | Chief Financial Officer | Jan 31, 2022 | Sale | $27.40 | 1,238 | 33,921 | 37,855 | Feb 02, 2022, 04:17 PM |
| Dube Eric M | Chief Executive Officer | Jan 31, 2022 | Sale | $27.40 | 4,813 | 131,876 | 164,745 | Feb 02, 2022, 04:16 PM |
| Calvin Sandra | VP, Corp Controller and CAO | Jan 24, 2022 | Sale | $24.58 | 934 | 22,955 | 28,662 | Jan 26, 2022, 04:38 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 36,520 | Jan 26, 2022, 04:37 PM |
| Heerma Peter | Chief Commercial Officer | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 58,582 | Jan 26, 2022, 04:36 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2022 | Sale | $24.98 | 2,250 | 56,205 | 35,298 | Jan 26, 2022, 04:35 PM |
| Clague Laura | Chief Financial Officer | Jan 24, 2022 | Sale | $24.98 | 2,063 | 51,534 | 29,253 | Jan 26, 2022, 04:34 PM |
| Dube Eric M | Chief Executive Officer | Jan 24, 2022 | Sale | $24.98 | 7,873 | 196,668 | 131,710 | Jan 26, 2022, 04:33 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 11, 2022 | Sale | $27.40 | 5,000 | 137,000 | 37,548 | Jan 12, 2022, 04:07 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 11, 2022 | Sale | $27.40 | 2,500 | 68,500 | 38,395 | Jan 12, 2022, 04:06 PM |
| Clague Laura | Chief Financial Officer | Jan 11, 2022 | Sale | $27.40 | 7,500 | 205,500 | 31,316 | Jan 12, 2022, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2022 | Sale | $29.95 | 12,500 | 374,369 | 141,722 | Jan 06, 2022, 04:03 PM |
| Dube Eric M | Chief Executive Officer | Jan 04, 2022 | Sale | $30.43 | 4,832 | 147,038 | 152,083 | Jan 06, 2022, 04:03 PM |
| ASELAGE STEVE | Director | Nov 16, 2021 | Sale | $29.39 | 31,800 | 934,602 | 149,494 | Nov 18, 2021, 04:08 PM |
| ASELAGE STEVE | Director | Nov 05, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 171,794 | Nov 09, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 05, 2021 | Sale | $26.23 | 10,000 | 262,300 | 161,794 | Nov 09, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 02, 2021 | Sale | $30.00 | 3,500 | 105,000 | 19,500 | Nov 03, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 01, 2021 | Sale | $29.48 | 5,000 | 147,400 | 23,000 | Nov 03, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Oct 07, 2021 | Option Exercise | $16.23 | 60,000 | 973,800 | 249,794 | Oct 08, 2021, 04:18 PM |
| ASELAGE STEVE | Director | Oct 07, 2021 | Sale | $26.25 | 60,000 | 1,574,760 | 221,794 | Oct 08, 2021, 04:18 PM |
| Heerma Peter | Chief Commercial Officer | Oct 04, 2021 | Sale | $24.77 | 3,058 | 75,746 | 60,457 | Oct 05, 2021, 04:06 PM |
| Heerma Peter | Chief Commercial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 63,515 | Aug 17, 2021, 07:41 PM |
| Dube Eric M | Chief Executive Officer | Aug 17, 2021 | Sale | $17.12 | 7,836 | 134,142 | 156,915 | Aug 17, 2021, 07:40 PM |
| Rosenberg Noah L. | Chief Medical Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 47,614 | Aug 17, 2021, 07:39 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 35,731 | Aug 17, 2021, 07:38 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 37,548 | Aug 17, 2021, 07:35 PM |
| Clague Laura | Chief Financial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 31,316 | Aug 17, 2021, 07:34 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2021 | Sale | $13.81 | 1,250 | 17,263 | 44,521 | Jul 29, 2021, 04:09 PM |
| ASELAGE STEVE | Director | Apr 16, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 198,940 | Apr 20, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Apr 16, 2021 | Sale | $26.23 | 10,000 | 262,300 | 188,940 | Apr 20, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Mar 17, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 206,667 | Mar 19, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Mar 17, 2021 | Sale | $27.44 | 17,727 | 486,456 | 196,667 | Mar 19, 2021, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 18, 2021 | Sale | $28.67 | 1,250 | 35,838 | 34,832 | Feb 18, 2021, 06:26 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 17, 2021 | Sale | $27.35 | 1,250 | 34,188 | 36,082 | Feb 18, 2021, 06:26 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 46,344 | Feb 09, 2021, 04:32 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 47,469 | Feb 09, 2021, 04:32 PM |
| Heerma Peter | Chief Commercial Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 59,344 | Feb 09, 2021, 04:31 PM |
| Heerma Peter | Chief Commercial Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 60,469 | Feb 09, 2021, 04:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,332 | Feb 09, 2021, 04:30 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,582 | Feb 09, 2021, 04:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,705 | Feb 09, 2021, 04:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,955 | Feb 09, 2021, 04:30 PM |
| Clague Laura | Chief Financial Officer | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 32,223 | Feb 09, 2021, 04:29 PM |
| Clague Laura | Chief Financial Officer | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 34,473 | Feb 09, 2021, 04:29 PM |
| Dube Eric M | Chief Executive Officer | Feb 05, 2021 | Sale | $31.41 | 4,813 | 151,176 | 161,626 | Feb 09, 2021, 04:28 PM |
| Dube Eric M | Chief Executive Officer | Feb 08, 2021 | Sale | $31.58 | 4,813 | 151,995 | 156,813 | Feb 09, 2021, 04:28 PM |
| Heerma Peter | Chief Commercial Officer | Feb 03, 2021 | Sale | $28.91 | 563 | 16,276 | 57,094 | Feb 03, 2021, 09:33 PM |
| Heerma Peter | Chief Commercial Officer | Feb 02, 2021 | Sale | $30.75 | 563 | 17,312 | 57,657 | Feb 03, 2021, 09:33 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 03, 2021 | Sale | $28.91 | 1,813 | 52,414 | 44,657 | Feb 03, 2021, 09:33 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 03, 2021 | Sale | $28.91 | 3,625 | 104,799 | 38,457 | Feb 03, 2021, 09:32 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 03, 2021 | Sale | $28.91 | 3,175 | 91,789 | 38,380 | Feb 03, 2021, 09:31 PM |
| Clague Laura | Chief Financial Officer | Feb 03, 2021 | Sale | $28.91 | 3,625 | 104,799 | 33,348 | Feb 03, 2021, 09:30 PM |
| Dube Eric M | Chief Executive Officer | Feb 03, 2021 | Sale | $28.91 | 2,406 | 69,557 | 148,939 | Feb 03, 2021, 09:29 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 02, 2021 | Sale | $30.75 | 1,813 | 55,750 | 46,470 | Feb 02, 2021, 09:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 02, 2021 | Sale | $30.75 | 3,625 | 111,469 | 43,457 | Feb 02, 2021, 09:23 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 02, 2021 | Sale | $30.75 | 3,175 | 97,631 | 41,555 | Feb 02, 2021, 09:21 PM |
| Dube Eric M | Chief Executive Officer | Feb 02, 2021 | Sale | $29.91 | 8,734 | 261,267 | 153,751 | Feb 02, 2021, 09:20 PM |
| Clague Laura | Chief Financial Officer | Feb 02, 2021 | Sale | $30.75 | 3,625 | 111,469 | 36,973 | Feb 02, 2021, 09:19 PM |
| ASELAGE STEVE | Director | Feb 02, 2021 | Option Exercise | $10.09 | 25,000 | 252,250 | 221,667 | Feb 02, 2021, 09:18 PM |
| ASELAGE STEVE | Director | Feb 02, 2021 | Sale | $30.75 | 25,000 | 768,750 | 196,667 | Feb 02, 2021, 09:18 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 06, 2021 | Sale | $27.01 | 688 | 18,583 | 24,055 | Jan 07, 2021, 06:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 05, 2021 | Sale | $26.65 | 688 | 18,335 | 24,743 | Jan 07, 2021, 06:30 PM |
| Dube Eric M | Chief Executive Officer | Jan 06, 2021 | Sale | $27.01 | 3,438 | 92,860 | 87,819 | Jan 07, 2021, 06:29 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2021 | Sale | $26.65 | 3,438 | 91,623 | 91,257 | Jan 07, 2021, 06:29 PM |
| ASELAGE STEVE | Director | Dec 15, 2020 | Sale | $26.02 | 5,549 | 144,385 | 196,667 | Dec 16, 2020, 08:55 PM |
| ASELAGE STEVE | Director | Dec 02, 2020 | Sale | $23.43 | 7,891 | 184,849 | 202,216 | Dec 04, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 25, 2020 | Sale | $22.72 | 3,750 | 85,200 | 19,473 | Nov 25, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 24, 2020 | Sale | $23.86 | 3,750 | 89,475 | 23,223 | Nov 25, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 16, 2020 | Sale | $23.98 | 7,500 | 179,813 | 19,473 | Nov 17, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 16, 2020 | Sale | $23.96 | 2,500 | 59,900 | 24,086 | Nov 17, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 16, 2020 | Sale | $23.98 | 2,500 | 59,950 | 25,431 | Nov 17, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 13, 2020 | Sale | $23.62 | 2,500 | 59,046 | 27,931 | Nov 13, 2020, 09:26 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 13, 2020 | Sale | $23.62 | 2,500 | 59,056 | 26,586 | Nov 13, 2020, 09:25 PM |
| Clague Laura | Chief Financial Officer | Nov 13, 2020 | Sale | $23.61 | 7,500 | 177,071 | 26,973 | Nov 13, 2020, 09:24 PM |
| ASELAGE STEVE | Director | Nov 06, 2020 | Sale | $23.00 | 20,625 | 474,375 | 213,107 | Nov 06, 2020, 08:56 PM |
| ASELAGE STEVE | Director | Nov 05, 2020 | Sale | $21.26 | 2,500 | 53,150 | 233,732 | Nov 06, 2020, 08:56 PM |
| Heerma Peter | Chief Commercial Officer | Oct 02, 2020 | Sale | $18.90 | 2,188 | 41,353 | 44,517 | Oct 05, 2020, 08:31 PM |
| Heerma Peter | Chief Commercial Officer | Oct 05, 2020 | Sale | $19.35 | 2,188 | 42,338 | 42,329 | Oct 05, 2020, 08:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 24,086 | Sep 23, 2020, 08:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 25,431 | Sep 23, 2020, 08:00 PM |
| Rosenberg Noah L. | Chief Medical Officer | Sep 23, 2020 | Sale | $18.48 | 750 | 13,860 | 27,555 | Sep 23, 2020, 08:00 PM |
| Clague Laura | Chief Financial Officer | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 19,473 | Sep 23, 2020, 08:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 25,586 | Sep 22, 2020, 09:20 PM |
| Rosenberg Noah L. | Chief Medical Officer | Sep 22, 2020 | Sale | $18.59 | 750 | 13,943 | 28,305 | Sep 22, 2020, 09:20 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 26,931 | Sep 22, 2020, 09:18 PM |
| Clague Laura | Chief Financial Officer | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 20,973 | Sep 22, 2020, 09:18 PM |
| Dube Eric M | Chief Executive Officer | Sep 21, 2020 | Sale | $19.28 | 10,805 | 208,319 | 96,260 | Sep 22, 2020, 09:15 PM |
| ASELAGE STEVE | Director | Aug 05, 2020 | Sale | $19.68 | 2,500 | 49,200 | 236,232 | Aug 06, 2020, 04:07 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2020 | Sale | $20.49 | 870 | 17,826 | 26,055 | Jul 30, 2020, 07:48 PM |
| ASELAGE STEVE | Director | Jun 25, 2020 | Sale | $20.00 | 10,000 | 200,000 | 238,732 | Jun 29, 2020, 09:02 PM |
| ASELAGE STEVE | Director | May 14, 2020 | Sale | $15.09 | 3,062 | 46,206 | 245,732 | May 14, 2020, 08:59 PM |
| ASELAGE STEVE | Director | May 13, 2020 | Sale | $16.41 | 4,063 | 66,674 | 248,794 | May 14, 2020, 08:59 PM |
| ASELAGE STEVE | Director | May 12, 2020 | Sale | $17.16 | 1,000 | 17,160 | 252,857 | May 14, 2020, 08:59 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 12, 2020 | Sale | $17.07 | 1,052 | 17,960 | 25,958 | May 13, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 11, 2020 | Sale | $14.95 | 525 | 7,849 | 26,483 | May 13, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 11, 2020 | Sale | $14.95 | 813 | 12,154 | 24,833 | May 13, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 12, 2020 | Sale | $17.09 | 1,339 | 22,885 | 24,021 | May 13, 2020, 09:00 PM |
| Clague Laura | Chief Financial Officer | May 12, 2020 | Sale | $17.11 | 1,777 | 30,401 | 20,000 | May 13, 2020, 09:00 PM |
| Clague Laura | Chief Financial Officer | May 11, 2020 | Sale | $14.95 | 1,250 | 18,687 | 21,250 | May 13, 2020, 09:00 PM |
| Rosenberg Noah L. | Chief Medical Officer | May 12, 2020 | Sale | $16.98 | 527 | 8,951 | 26,728 | May 13, 2020, 09:00 PM |
| ASELAGE STEVE | Director | May 05, 2020 | Sale | $15.88 | 2,500 | 39,700 | 253,857 | May 06, 2020, 04:09 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Mar 10, 2020 | Sale | $14.87 | 3,250 | 48,327 | 25,646 | Mar 12, 2020, 07:45 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Mar 10, 2020 | Sale | $15.02 | 3,500 | 52,570 | 27,008 | Mar 12, 2020, 07:44 PM |
| Clague Laura | Chief Financial Officer | Mar 10, 2020 | Sale | $15.02 | 4,000 | 60,080 | 22,500 | Mar 12, 2020, 07:43 PM |
| Rosenberg Noah L. | Chief Medical Officer | Mar 05, 2020 | Sale | $15.36 | 1,790 | 27,487 | 27,255 | Mar 09, 2020, 09:05 PM |
| ASELAGE STEVE | Director | Mar 05, 2020 | Sale | $15.36 | 4,359 | 66,939 | 256,357 | Mar 09, 2020, 09:03 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 18, 2020 | Sale | $16.55 | 1,250 | 20,687 | 25,646 | Feb 19, 2020, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 14, 2020 | Sale | $16.72 | 1,250 | 20,900 | 26,896 | Feb 19, 2020, 04:05 PM |
| ASELAGE STEVE | Director | Feb 05, 2020 | Sale | $16.62 | 2,500 | 41,550 | 248,466 | Feb 07, 2020, 07:38 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 07, 2020 | Sale | $13.94 | 750 | 10,455 | 18,758 | Jan 08, 2020, 09:01 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 08, 2020 | Sale | $15.14 | 750 | 11,355 | 18,008 | Jan 08, 2020, 09:01 PM |
| Dube Eric M | Chief Executive Officer | Jan 08, 2020 | Sale | $15.14 | 3,750 | 56,775 | 42,500 | Jan 08, 2020, 08:49 PM |
| Dube Eric M | Chief Executive Officer | Jan 07, 2020 | Sale | $13.94 | 3,750 | 52,275 | 46,250 | Jan 08, 2020, 08:49 PM |
| ASELAGE STEVE | Director | Nov 29, 2019 | Sale | $13.91 | 5,000 | 69,552 | 250,966 | Nov 29, 2019, 09:27 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 31, 2019 | Sale | $20.07 | 1,250 | 25,087 | 13,500 | Jul 31, 2019, 09:15 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 30, 2019 | Sale | $19.82 | 1,250 | 24,775 | 14,750 | Jul 31, 2019, 09:15 PM |
| McFarlane Neil F. | Chief Operating Officer | May 16, 2019 | Sale | $18.71 | 984 | 18,411 | 26,988 | May 16, 2019, 09:37 PM |
| McFarlane Neil F. | Chief Operating Officer | May 15, 2019 | Sale | $17.78 | 984 | 17,496 | 27,972 | May 16, 2019, 09:37 PM |
| Clague Laura | Chief Financial Officer | May 15, 2019 | Sale | $17.78 | 1,250 | 22,225 | 14,750 | May 16, 2019, 09:37 PM |
| Clague Laura | Chief Financial Officer | May 16, 2019 | Sale | $18.71 | 1,250 | 23,387 | 13,500 | May 16, 2019, 09:37 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 15, 2019 | Sale | $17.76 | 812 | 14,421 | 18,185 | May 16, 2019, 09:36 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 14, 2019 | Sale | $17.78 | 813 | 14,455 | 18,997 | May 16, 2019, 09:36 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 14, 2019 | Sale | $17.75 | 525 | 9,319 | 20,033 | May 16, 2019, 09:35 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 15, 2019 | Sale | $17.71 | 525 | 9,298 | 19,508 | May 16, 2019, 09:35 PM |
| ASELAGE STEVE | Director | May 15, 2019 | Sale | $17.82 | 1,838 | 32,753 | 255,966 | May 16, 2019, 09:34 PM |
| ASELAGE STEVE | Director | May 14, 2019 | Sale | $17.79 | 1,838 | 32,698 | 257,804 | May 16, 2019, 09:34 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 19, 2019 | Sale | $21.52 | 1,250 | 26,900 | 13,810 | Feb 20, 2019, 07:58 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 15, 2019 | Sale | $21.44 | 1,250 | 26,800 | 15,060 | Feb 20, 2019, 07:58 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 11, 2019 | Sale | $21.38 | 885 | 18,921 | 15,442 | Feb 13, 2019, 08:50 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 12, 2019 | Sale | $21.50 | 884 | 19,006 | 14,558 | Feb 13, 2019, 08:50 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 12, 2019 | Sale | $21.50 | 992 | 21,328 | 16,007 | Feb 13, 2019, 08:49 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 11, 2019 | Sale | $21.38 | 993 | 21,230 | 16,999 | Feb 13, 2019, 08:49 PM |
| Clague Laura | Chief Financial Officer | Feb 12, 2019 | Sale | $21.50 | 1,016 | 21,844 | 10,000 | Feb 13, 2019, 08:49 PM |
| Clague Laura | Chief Financial Officer | Feb 11, 2019 | Sale | $21.38 | 1,017 | 21,743 | 11,016 | Feb 13, 2019, 08:49 PM |
| ASELAGE STEVE | Chief Executive Officer | Feb 12, 2019 | Sale | $21.50 | 1,065 | 22,898 | 257,642 | Feb 13, 2019, 08:47 PM |
| ASELAGE STEVE | Chief Executive Officer | Feb 11, 2019 | Sale | $21.38 | 1,065 | 22,770 | 258,707 | Feb 13, 2019, 08:47 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 09, 2019 | Sale | $23.82 | 750 | 17,865 | 16,327 | Jan 09, 2019, 07:43 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 08, 2019 | Sale | $24.09 | 750 | 18,068 | 17,077 | Jan 09, 2019, 07:43 PM |
| McFarlane Neil F. | Chief Operating Officer | Dec 20, 2018 | Sale | $22.32 | 11,125 | 248,333 | 35,360 | Dec 21, 2018, 08:21 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 20, 2018 | Sale | $21.97 | 6,188 | 135,958 | 265,960 | Dec 21, 2018, 08:20 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 21, 2018 | Sale | $21.79 | 6,188 | 134,829 | 260,672 | Dec 21, 2018, 08:20 PM |
| Clague Laura | Chief Financial Officer | Dec 21, 2018 | Sale | $21.83 | 3,750 | 81,860 | 12,933 | Dec 21, 2018, 08:19 PM |
| Clague Laura | Chief Financial Officer | Dec 20, 2018 | Sale | $22.08 | 3,750 | 82,804 | 15,783 | Dec 21, 2018, 08:19 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 07, 2018 | Sale | $24.04 | 10 | 240 | 251,523 | Dec 07, 2018, 09:15 PM |
| McFarlane Neil F. | Chief Operating Officer | Nov 14, 2018 | Sale | $23.73 | 10,000 | 237,314 | 29,476 | Nov 16, 2018, 07:19 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 15, 2018 | Sale | $24.33 | 2,500 | 60,816 | 18,027 | Nov 16, 2018, 07:18 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 14, 2018 | Sale | $23.73 | 2,500 | 59,330 | 20,627 | Nov 16, 2018, 07:18 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 15, 2018 | Sale | $24.32 | 2,500 | 60,800 | 18,304 | Nov 16, 2018, 07:17 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 14, 2018 | Sale | $23.73 | 2,500 | 59,329 | 20,792 | Nov 16, 2018, 07:17 PM |
| Clague Laura | Chief Financial Officer | Nov 15, 2018 | Sale | $24.31 | 3,750 | 91,167 | 12,824 | Nov 16, 2018, 07:16 PM |
| Clague Laura | Chief Financial Officer | Nov 14, 2018 | Sale | $23.73 | 3,750 | 88,970 | 16,183 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 15, 2018 | Sale | $24.32 | 5,550 | 134,969 | 254,369 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 14, 2018 | Sale | $23.74 | 5,550 | 131,735 | 259,433 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Aug 31, 2018 | Option Exercise | $8.70 | 12,000 | 104,400 | 257,883 | Aug 31, 2018, 07:54 PM |
| ASELAGE STEVE | Chief Executive Officer | Aug 31, 2018 | Sale | $32.00 | 12,000 | 384,000 | 245,883 | Aug 31, 2018, 07:54 PM |
| ASELAGE STEVE | Chief Executive Officer | Mar 07, 2018 | Option Exercise | $6.00 | 278 | 1,668 | 221,383 | Mar 08, 2018, 09:13 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 14, 2018 | Sale | $21.50 | 1,034 | 22,232 | 11,156 | Feb 16, 2018, 07:39 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 05, 2018 | Sale | $24.04 | 942 | 22,646 | 9,058 | Jan 08, 2018, 07:58 PM |
| McFarlane Neil F. | Chief Operating Officer | Aug 16, 2017 | Sale | $22.50 | 1,378 | 31,005 | 13,622 | Aug 17, 2017, 08:36 PM |
| ASELAGE STEVE | Chief Executive Officer | Jun 14, 2017 | Buy | $17.85 | 5,000 | 89,250 | 245,556 | Jun 14, 2017, 02:40 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 21, 2016 | Sale | $21.00 | 5,000 | 105,000 | 243,756 | Nov 23, 2016, 04:25 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 22, 2016 | Sale | $21.30 | 3,200 | 68,160 | 240,556 | Nov 23, 2016, 04:25 PM |
| Shih Alvin | EVP of Research & Development | Sep 01, 2016 | Sale | $16.24 | 8,750 | 142,059 | 158,334 | Sep 02, 2016, 09:26 PM |
| Shih Alvin | EVP of Research & Development | Jun 01, 2016 | Sale | $17.75 | 8,750 | 155,284 | 167,084 | Jun 02, 2016, 09:04 PM |
| Meckler Jeffrey A | Director | Mar 04, 2016 | Buy | $15.31 | 5,000 | 76,564 | 52,000 | Mar 07, 2016, 08:50 PM |
| Meckler Jeffrey A | Director | Mar 03, 2016 | Buy | $14.45 | 10,000 | 144,500 | 47,000 | Mar 03, 2016, 06:49 PM |
| Shih Alvin | EVP of Research & Development | Mar 01, 2016 | Sale | $14.35 | 8,750 | 125,569 | 175,834 | Mar 01, 2016, 06:35 PM |
| Shih Alvin | EVP of Research & Development | Dec 09, 2015 | Sale | $20.83 | 8,750 | 182,262 | 184,584 | Dec 10, 2015, 08:50 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 10, 2015 | Sale | $18.72 | 30,000 | 561,600 | 308,756 | Nov 12, 2015, 01:03 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 09, 2015 | Sale | $18.77 | 30,000 | 563,100 | 338,756 | Nov 12, 2015, 01:03 PM |
| VALEUR JENSEN MARGARET E | General Counsel | Nov 02, 2015 | Sale | $20.46 | 50,000 | 1,022,949 | 55,336 | Nov 04, 2015, 07:04 PM |
| Shih Alvin | EVP of Research & Development | Oct 06, 2015 | Sale | $20.12 | 8,750 | 176,073 | 197,286 | Oct 08, 2015, 09:49 PM |
| Shih Alvin | EVP of Research & Development | Jun 26, 2015 | Sale | $32.70 | 27,916 | 912,850 | 202,084 | Jun 30, 2015, 05:32 PM |
| Plotkin Horacio | Chief Medical Officer | Dec 12, 2014 | Sale | $10.07 | 2,100 | 21,146 | 91,767 | Dec 16, 2014, 02:30 PM |
| Meckler Jeffrey A | Director | Nov 25, 2014 | Buy | $8.60 | 15,000 | 129,050 | 35,000 | Nov 25, 2014, 03:16 PM |
| Richardson Steven Gary | Director | Nov 21, 2014 | Buy | $8.38 | 6,100 | 51,118 | 129,165 | Nov 24, 2014, 07:43 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 14, 2014 | Sale | $10.23 | 100,000 | 1,022,790 | 2,837,168 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 21, 2014 | Sale | $8.41 | 252,847 | 2,126,443 | 1,765,168 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 20, 2014 | Sale | $8.23 | 134,354 | 1,105,989 | 2,018,015 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 19, 2014 | Sale | $8.54 | 329,824 | 2,817,093 | 2,152,369 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 18, 2014 | Sale | $9.19 | 254,975 | 2,343,501 | 2,482,193 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 17, 2014 | Sale | $9.41 | 100,000 | 941,100 | 2,737,168 | Nov 24, 2014, 02:55 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 21, 2014 | Buy | $8.50 | 8,700 | 73,950 | 371,756 | Nov 21, 2014, 06:02 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 20, 2014 | Buy | $8.20 | 1,300 | 10,660 | 363,056 | Nov 21, 2014, 06:02 PM |
| Golding Cornelius E | Director | Nov 19, 2014 | Buy | $9.00 | 2,000 | 18,000 | 25,000 | Nov 19, 2014, 05:39 PM |
| Plotkin Horacio | Chief Medical Officer | Nov 17, 2014 | Sale | $9.43 | 8,333 | 78,594 | 93,867 | Nov 19, 2014, 05:37 PM |
| Shkreli Martin | Chief Executive Officer | Oct 01, 2014 | Buy | $8.11 | 25,000 | 202,665 | 2,962,168 | Oct 09, 2014, 11:11 AM |
| Shkreli Martin | Chief Executive Officer | Oct 01, 2014 | Sale | $0.01 | 300,000 | 3,000 | 2,662,168 | Oct 09, 2014, 11:11 AM |
| Shkreli Martin | Chief Executive Officer | Sep 30, 2014 | Buy | $9.42 | 4,000 | 37,680 | 2,937,168 | Oct 02, 2014, 09:30 PM |
| Shkreli Martin | Chief Executive Officer | Sep 22, 2014 | Buy | $10.82 | 35,000 | 378,707 | 2,933,168 | Sep 23, 2014, 10:54 AM |
| Shkreli Martin | Chief Executive Officer | Sep 19, 2014 | Buy | $11.78 | 18,000 | 212,035 | 2,898,168 | Sep 23, 2014, 10:54 AM |
| Shkreli Martin | Chief Executive Officer | Sep 17, 2014 | Buy | $11.46 | 6,000 | 68,740 | 2,880,168 | Sep 18, 2014, 11:28 AM |
| Shkreli Martin | Chief Executive Officer | Sep 16, 2014 | Buy | $10.69 | 7,500 | 80,190 | 2,874,168 | Sep 16, 2014, 07:51 PM |
| Paley Jeffrey | Director | Aug 14, 2014 | Sale | $12.28 | 20,000 | 245,598 | 51,665 | Aug 18, 2014, 05:51 PM |
| Shkreli Martin | Chief Executive Officer | May 30, 2014 | Option Exercise | $14.62 | 176,388 | 2,578,793 | 3,159,068 | Jun 03, 2014, 09:50 PM |
| Shkreli Martin | Chief Executive Officer | May 30, 2014 | Sale | $15.14 | 292,400 | 4,426,936 | 2,866,668 | Jun 03, 2014, 09:50 PM |
| Shkreli Martin | Chief Executive Officer | Apr 04, 2014 | Buy | $19.64 | 8,000 | 157,145 | 2,982,680 | Apr 07, 2014, 10:16 AM |
| Shkreli Martin | Chief Executive Officer | Apr 03, 2014 | Buy | $22.60 | 22,500 | 508,442 | 2,974,680 | Apr 04, 2014, 11:53 AM |
| Shkreli Martin | Chief Executive Officer | Apr 02, 2014 | Buy | $22.28 | 10,800 | 240,615 | 2,952,180 | Apr 03, 2014, 09:34 AM |
| Shkreli Martin | Chief Executive Officer | Mar 24, 2014 | Buy | $17.61 | 4,000 | 70,440 | 2,941,380 | Mar 27, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 20, 2014 | Buy | $17.97 | 5,000 | 89,850 | 2,937,380 | Mar 21, 2014, 01:36 PM |
| Shkreli Martin | Chief Executive Officer | Mar 19, 2014 | Buy | $18.44 | 3,500 | 64,557 | 2,932,380 | Mar 20, 2014, 12:24 PM |
| Shkreli Martin | Chief Executive Officer | Mar 14, 2014 | Buy | $17.36 | 4,000 | 69,445 | 2,928,880 | Mar 17, 2014, 04:15 PM |
| Shkreli Martin | Chief Executive Officer | Mar 11, 2014 | Buy | $19.47 | 25,900 | 504,387 | 2,924,880 | Mar 12, 2014, 09:49 AM |
| Shkreli Martin | Chief Executive Officer | Mar 10, 2014 | Buy | $19.32 | 10,700 | 206,711 | 2,898,980 | Mar 11, 2014, 10:45 AM |
| Shkreli Martin | Chief Executive Officer | Mar 07, 2014 | Buy | $18.26 | 2,498 | 45,618 | 2,888,280 | Mar 10, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 06, 2014 | Buy | $18.93 | 1,560 | 29,528 | 2,885,782 | Mar 10, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 05, 2014 | Buy | $18.48 | 4,000 | 73,906 | 2,884,222 | Mar 06, 2014, 09:32 AM |
| Shkreli Martin | Chief Executive Officer | Feb 28, 2014 | Buy | $18.67 | 43,000 | 802,677 | 2,880,222 | Mar 03, 2014, 10:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 21, 2014 | Buy | $17.20 | 100 | 1,720 | 2,837,222 | Mar 03, 2014, 10:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 21, 2014 | Buy | $17.56 | 1,600 | 28,102 | 2,837,122 | Feb 25, 2014, 09:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 14, 2014 | Buy | $14.60 | 3,500 | 51,106 | 2,835,522 | Feb 19, 2014, 10:40 AM |
| Shkreli Martin | Chief Executive Officer | Feb 06, 2014 | Buy | $9.92 | 2,000 | 19,832 | 2,832,022 | Feb 07, 2014, 12:52 PM |
| Shkreli Martin | Chief Executive Officer | Jan 14, 2014 | Buy | $10.84 | 8,000 | 86,694 | 2,830,022 | Jan 15, 2014, 06:01 AM |
| Shkreli Martin | Chief Executive Officer | Sep 12, 2013 | Buy | $4.50 | 5,556 | 25,002 | 2,665,596 | Jan 14, 2014, 07:04 PM |
| Shkreli Martin | Chief Executive Officer | Dec 31, 2013 | Buy | $7.00 | 150,000 | 1,050,000 | 2,816,246 | Jan 02, 2014, 06:41 AM |
| Richardson Steven Gary | Director | Aug 15, 2013 | Buy | $4.50 | 1,110 | 4,995 | 99,165 | Dec 30, 2013, 04:30 PM |
| ASELAGE STEVE | Director | Aug 15, 2013 | Buy | $4.50 | 556 | 2,502 | 261,756 | Dec 27, 2013, 07:59 PM |
| Golding Cornelius E | Director | Dec 24, 2013 | Buy | $7.50 | 3,000 | 22,500 | 3,000 | Dec 27, 2013, 04:04 PM |
| Shkreli Martin | Chief Executive Officer | Dec 09, 2013 | Buy | $8.11 | 100 | 811 | 2,666,246 | Dec 10, 2013, 02:33 PM |
| Shkreli Martin | Chief Executive Officer | Dec 06, 2013 | Buy | $8.30 | 100 | 830 | 2,666,146 | Dec 10, 2013, 02:33 PM |
| Shkreli Martin | Chief Executive Officer | Nov 26, 2013 | Buy | $6.81 | 150 | 1,021 | 2,666,046 | Dec 02, 2013, 03:51 PM |
| Shkreli Martin | Chief Executive Officer | Nov 22, 2013 | Buy | $6.06 | 300 | 1,818 | 2,665,896 | Dec 02, 2013, 03:51 PM |
| Richardson Steven Gary | Director | Nov 05, 2013 | Buy | $6.90 | 2,900 | 20,010 | 102,065 | Nov 08, 2013, 06:09 PM |
| Shkreli Martin | Chief Executive Officer | Sep 12, 2013 | Buy | $4.50 | 11,112 | 50,004 | 2,671,152 | Sep 16, 2013, 05:11 PM |
| Plotkin Horacio | Chief Medical Officer | Aug 15, 2013 | Buy | $4.50 | 2,200 | 9,900 | 2,200 | Aug 23, 2013, 02:15 PM |
| Shkreli Martin | Chief Executive Officer | Aug 22, 2013 | Buy | $6.02 | 1,100 | 6,622 | 2,660,040 | Aug 23, 2013, 02:15 PM |
| Shkreli Martin | Chief Executive Officer | Aug 21, 2013 | Buy | $6.08 | 2,800 | 17,024 | 2,658,940 | Aug 23, 2013, 02:15 PM |
| PANOFF MARC L | Chief Financial Officer | Aug 15, 2013 | Buy | $4.50 | 1,100 | 4,950 | 121,100 | Aug 20, 2013, 05:33 PM |
| Shkreli Martin | Chief Executive Officer | Mar 06, 2013 | Buy | $4.25 | 100 | 425 | 2,655,740 | Mar 12, 2013, 01:31 PM |
| Shkreli Martin | Chief Executive Officer | Mar 11, 2013 | Buy | $4.70 | 400 | 1,880 | 2,656,140 | Mar 12, 2013, 01:31 PM |
| Shkreli Martin | Chief Executive Officer | Mar 04, 2013 | Buy | $4.43 | 1,000 | 4,425 | 2,655,640 | Mar 06, 2013, 02:21 PM |
| Shkreli Martin | Chief Executive Officer | Feb 20, 2013 | Buy | $4.16 | 1,120 | 4,662 | 2,654,640 | Feb 21, 2013, 02:44 PM |
| Shkreli Martin | Chief Executive Officer | Feb 14, 2013 | Buy | $3.00 | 120,000 | 360,000 | 2,653,520 | Feb 19, 2013, 04:14 PM |
| Shkreli Martin | Chief Executive Officer | Feb 12, 2013 | Buy | $3.57 | 1,400 | 5,000 | 2,533,520 | Feb 13, 2013, 06:41 PM |
| Shkreli Martin | Chief Executive Officer | Dec 26, 2012 | Buy | $3.55 | 100 | 355 | 2,532,120 | Dec 28, 2012, 12:30 PM |
| Shkreli Martin | Chief Executive Officer | Dec 17, 2012 | Buy | $7.69 | 100 | 769 | 2,532,020 | Dec 28, 2012, 12:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/01/2023 | 57,628 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/01/2023 | 57,628 |
| Heerma Peter | Chief Commercial Officer | 02/01/2023 | 38,697 |
| Cline Christopher R. | Chief Financial Officer | 02/01/2023 | 34,542 |
| Dube Eric M | Chief Executive Officer | 02/01/2023 | 182,361 |
| Calvin Sandra | SVP, Chief Accounting Officer | 02/02/2023 | 8,071 |
| Calvin Sandra | SVP, Chief Accounting Officer | 02/01/2023 | 36,348 |
| Calvin Sandra | SVP, Chief Accounting Officer | 01/25/2023 | 4,153 |
| Calvin Sandra | SVP, Chief Accounting Officer | 01/24/2023 | 19,823 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/24/2023 | 44,333 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/24/2023 | 44,333 |
| Dube Eric M | Chief Executive Officer | 01/24/2023 | 138,503 |
| Cline Christopher R. | Chief Financial Officer | 01/24/2023 | 18,663 |
| Heerma Peter | Chief Commercial Officer | 01/24/2023 | 33,952 |
| Dube Eric M | Chief Executive Officer | 01/05/2023 | 116,719 |
| Inrig Jula | Chief Medical Officer | 01/05/2023 | 9,172 |
| Inrig Jula | Chief Medical Officer | 01/04/2023 | 42,558 |
| Heerma Peter | Chief Commercial Officer | 10/04/2022 | 78,119 |
| Calvin Sandra | SVP, Chief Accounting Officer | 09/13/2022 | 9,772 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/11/2022 | 33,940 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/12/2022 | 22,584 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/10/2022 | 19,359 |
| Clague Laura | Chief Financial Officer | 05/11/2022 | 29,576 |
| Clague Laura | Chief Financial Officer | 05/10/2022 | 17,746 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/10/2022 | 9,378 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/11/2022 | 9,756 |
| ASELAGE STEVE | Director | 05/11/2022 | 56,457 |
| Dube Eric M | Chief Executive Officer | 02/10/2022 | 134,523 |
| Calvin Sandra | VP, Corp Controller and CAO | 01/31/2022 | 21,152 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/31/2022 | 36,990 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/31/2022 | 30,825 |
| Heerma Peter | Chief Commercial Officer | 01/31/2022 | 30,825 |
| Clague Laura | Chief Financial Officer | 01/31/2022 | 33,921 |
| Dube Eric M | Chief Executive Officer | 01/31/2022 | 131,876 |
| Calvin Sandra | VP, Corp Controller and CAO | 01/24/2022 | 22,955 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/24/2022 | 46,837 |
| Heerma Peter | Chief Commercial Officer | 01/24/2022 | 46,837 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/24/2022 | 56,205 |
| Clague Laura | Chief Financial Officer | 01/24/2022 | 51,534 |
| Dube Eric M | Chief Executive Officer | 01/24/2022 | 196,668 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/11/2022 | 137,000 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/11/2022 | 68,500 |
| Clague Laura | Chief Financial Officer | 01/11/2022 | 205,500 |
| Dube Eric M | Chief Executive Officer | 01/05/2022 | 374,369 |
| Dube Eric M | Chief Executive Officer | 01/04/2022 | 147,038 |
| ASELAGE STEVE | Director | 11/16/2021 | 934,602 |
| ASELAGE STEVE | Director | 11/05/2021 | 162,300 |
| ASELAGE STEVE | Director | 11/05/2021 | 262,300 |
| ASELAGE STEVE | Director | 11/02/2021 | 105,000 |
| ASELAGE STEVE | Director | 11/01/2021 | 147,400 |
| ASELAGE STEVE | Director | 10/07/2021 | 973,800 |
| ASELAGE STEVE | Director | 10/07/2021 | 1,574,760 |
| Heerma Peter | Chief Commercial Officer | 10/04/2021 | 75,746 |
| Heerma Peter | Chief Commercial Officer | 08/17/2021 | 24,086 |
| Dube Eric M | Chief Executive Officer | 08/17/2021 | 134,142 |
| Rosenberg Noah L. | Chief Medical Officer | 08/17/2021 | 24,085 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 08/17/2021 | 24,085 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 08/17/2021 | 24,086 |
| Clague Laura | Chief Financial Officer | 08/17/2021 | 24,085 |
| Rosenberg Noah L. | Chief Medical Officer | 07/28/2021 | 17,263 |
| ASELAGE STEVE | Director | 04/16/2021 | 162,300 |
| ASELAGE STEVE | Director | 04/16/2021 | 262,300 |
| ASELAGE STEVE | Director | 03/17/2021 | 162,300 |
| ASELAGE STEVE | Director | 03/17/2021 | 486,456 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/18/2021 | 35,838 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/17/2021 | 34,188 |
| Rosenberg Noah L. | Chief Medical Officer | 02/08/2021 | 35,527 |
| Rosenberg Noah L. | Chief Medical Officer | 02/05/2021 | 35,336 |
| Heerma Peter | Chief Commercial Officer | 02/08/2021 | 35,527 |
| Heerma Peter | Chief Commercial Officer | 02/05/2021 | 35,336 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/08/2021 | 71,055 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/05/2021 | 70,672 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/08/2021 | 71,055 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/05/2021 | 70,672 |
| Clague Laura | Chief Financial Officer | 02/08/2021 | 71,055 |
| Clague Laura | Chief Financial Officer | 02/05/2021 | 70,672 |
| Dube Eric M | Chief Executive Officer | 02/05/2021 | 151,176 |
| Dube Eric M | Chief Executive Officer | 02/08/2021 | 151,995 |
| Heerma Peter | Chief Commercial Officer | 02/03/2021 | 16,276 |
| Heerma Peter | Chief Commercial Officer | 02/02/2021 | 17,312 |
| Rosenberg Noah L. | Chief Medical Officer | 02/03/2021 | 52,414 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/03/2021 | 104,799 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/03/2021 | 91,789 |
| Clague Laura | Chief Financial Officer | 02/03/2021 | 104,799 |
| Dube Eric M | Chief Executive Officer | 02/03/2021 | 69,557 |
| Rosenberg Noah L. | Chief Medical Officer | 02/02/2021 | 55,750 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/02/2021 | 111,469 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/02/2021 | 97,631 |
| Dube Eric M | Chief Executive Officer | 02/02/2021 | 261,267 |
| Clague Laura | Chief Financial Officer | 02/02/2021 | 111,469 |
| ASELAGE STEVE | Director | 02/02/2021 | 252,250 |
| ASELAGE STEVE | Director | 02/02/2021 | 768,750 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/06/2021 | 18,583 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/05/2021 | 18,335 |
| Dube Eric M | Chief Executive Officer | 01/06/2021 | 92,860 |
| Dube Eric M | Chief Executive Officer | 01/05/2021 | 91,623 |
| ASELAGE STEVE | Director | 12/15/2020 | 144,385 |
| ASELAGE STEVE | Director | 12/02/2020 | 184,849 |
| Clague Laura | Chief Financial Officer | 11/25/2020 | 85,200 |
| Clague Laura | Chief Financial Officer | 11/24/2020 | 89,475 |
| Clague Laura | Chief Financial Officer | 11/16/2020 | 179,813 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/16/2020 | 59,900 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/16/2020 | 59,950 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/13/2020 | 59,046 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/13/2020 | 59,056 |
| Clague Laura | Chief Financial Officer | 11/13/2020 | 177,071 |
| ASELAGE STEVE | Director | 11/06/2020 | 474,375 |
| ASELAGE STEVE | Director | 11/05/2020 | 53,150 |
| Heerma Peter | Chief Commercial Officer | 10/02/2020 | 41,353 |
| Heerma Peter | Chief Commercial Officer | 10/05/2020 | 42,338 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 09/23/2020 | 27,720 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 09/23/2020 | 27,720 |
| Rosenberg Noah L. | Chief Medical Officer | 09/23/2020 | 13,860 |
| Clague Laura | Chief Financial Officer | 09/23/2020 | 27,720 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 09/22/2020 | 27,885 |
| Rosenberg Noah L. | Chief Medical Officer | 09/22/2020 | 13,943 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 09/22/2020 | 27,885 |
| Clague Laura | Chief Financial Officer | 09/22/2020 | 27,885 |
| Dube Eric M | Chief Executive Officer | 09/21/2020 | 208,319 |
| ASELAGE STEVE | Director | 08/05/2020 | 49,200 |
| Rosenberg Noah L. | Chief Medical Officer | 07/28/2020 | 17,826 |
| ASELAGE STEVE | Director | 06/25/2020 | 200,000 |
| ASELAGE STEVE | Director | 05/14/2020 | 46,206 |
| ASELAGE STEVE | Director | 05/13/2020 | 66,674 |
| ASELAGE STEVE | Director | 05/12/2020 | 17,160 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/12/2020 | 17,960 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/11/2020 | 7,849 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/11/2020 | 12,154 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/12/2020 | 22,885 |
| Clague Laura | Chief Financial Officer | 05/12/2020 | 30,401 |
| Clague Laura | Chief Financial Officer | 05/11/2020 | 18,687 |
| Rosenberg Noah L. | Chief Medical Officer | 05/12/2020 | 8,951 |
| ASELAGE STEVE | Director | 05/05/2020 | 39,700 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 03/10/2020 | 48,327 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 03/10/2020 | 52,570 |
| Clague Laura | Chief Financial Officer | 03/10/2020 | 60,080 |
| Rosenberg Noah L. | Chief Medical Officer | 03/05/2020 | 27,487 |
| ASELAGE STEVE | Director | 03/05/2020 | 66,939 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/18/2020 | 20,687 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/14/2020 | 20,900 |
| ASELAGE STEVE | Director | 02/05/2020 | 41,550 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/07/2020 | 10,455 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/08/2020 | 11,355 |
| Dube Eric M | Chief Executive Officer | 01/08/2020 | 56,775 |
| Dube Eric M | Chief Executive Officer | 01/07/2020 | 52,275 |
| ASELAGE STEVE | Director | 11/29/2019 | 69,552 |
| Rosenberg Noah L. | Chief Medical Officer | 07/31/2019 | 25,087 |
| Rosenberg Noah L. | Chief Medical Officer | 07/30/2019 | 24,775 |
| McFarlane Neil F. | Chief Operating Officer | 05/16/2019 | 18,411 |
| McFarlane Neil F. | Chief Operating Officer | 05/15/2019 | 17,496 |
| Clague Laura | Chief Financial Officer | 05/15/2019 | 22,225 |
| Clague Laura | Chief Financial Officer | 05/16/2019 | 23,387 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/15/2019 | 14,421 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/14/2019 | 14,455 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/14/2019 | 9,319 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/15/2019 | 9,298 |
| ASELAGE STEVE | Director | 05/15/2019 | 32,753 |
| ASELAGE STEVE | Director | 05/14/2019 | 32,698 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/19/2019 | 26,900 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/15/2019 | 26,800 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/11/2019 | 18,921 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/12/2019 | 19,006 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/12/2019 | 21,328 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/11/2019 | 21,230 |
| Clague Laura | Chief Financial Officer | 02/12/2019 | 21,844 |
| Clague Laura | Chief Financial Officer | 02/11/2019 | 21,743 |
| ASELAGE STEVE | Chief Executive Officer | 02/12/2019 | 22,898 |
| ASELAGE STEVE | Chief Executive Officer | 02/11/2019 | 22,770 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/09/2019 | 17,865 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/08/2019 | 18,068 |
| McFarlane Neil F. | Chief Operating Officer | 12/20/2018 | 248,333 |
| ASELAGE STEVE | Chief Executive Officer | 12/20/2018 | 135,958 |
| ASELAGE STEVE | Chief Executive Officer | 12/21/2018 | 134,829 |
| Clague Laura | Chief Financial Officer | 12/21/2018 | 81,860 |
| Clague Laura | Chief Financial Officer | 12/20/2018 | 82,804 |
| ASELAGE STEVE | Chief Executive Officer | 12/07/2018 | 240 |
| McFarlane Neil F. | Chief Operating Officer | 11/14/2018 | 237,314 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/15/2018 | 60,816 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/14/2018 | 59,330 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/15/2018 | 60,800 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/14/2018 | 59,329 |
| Clague Laura | Chief Financial Officer | 11/15/2018 | 91,167 |
| Clague Laura | Chief Financial Officer | 11/14/2018 | 88,970 |
| ASELAGE STEVE | Chief Executive Officer | 11/15/2018 | 134,969 |
| ASELAGE STEVE | Chief Executive Officer | 11/14/2018 | 131,735 |
| ASELAGE STEVE | Chief Executive Officer | 08/31/2018 | 104,400 |
| ASELAGE STEVE | Chief Executive Officer | 08/31/2018 | 384,000 |
| ASELAGE STEVE | Chief Executive Officer | 03/07/2018 | 1,668 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/14/2018 | 22,232 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/05/2018 | 22,646 |
| McFarlane Neil F. | Chief Operating Officer | 08/16/2017 | 31,005 |
| ASELAGE STEVE | Chief Executive Officer | 06/14/2017 | 89,250 |
| ASELAGE STEVE | Chief Executive Officer | 11/21/2016 | 105,000 |
| ASELAGE STEVE | Chief Executive Officer | 11/22/2016 | 68,160 |
| Shih Alvin | EVP of Research & Development | 09/01/2016 | 142,059 |
| Shih Alvin | EVP of Research & Development | 06/01/2016 | 155,284 |
| Meckler Jeffrey A | Director | 03/04/2016 | 76,564 |
| Meckler Jeffrey A | Director | 03/03/2016 | 144,500 |
| Shih Alvin | EVP of Research & Development | 03/01/2016 | 125,569 |
| Shih Alvin | EVP of Research & Development | 12/09/2015 | 182,262 |
| ASELAGE STEVE | Chief Executive Officer | 11/10/2015 | 561,600 |
| ASELAGE STEVE | Chief Executive Officer | 11/09/2015 | 563,100 |
| VALEUR JENSEN MARGARET E | General Counsel | 11/02/2015 | 1,022,949 |
| Shih Alvin | EVP of Research & Development | 10/06/2015 | 176,073 |
| Shih Alvin | EVP of Research & Development | 06/26/2015 | 912,850 |
| Plotkin Horacio | Chief Medical Officer | 12/12/2014 | 21,146 |
| Meckler Jeffrey A | Director | 11/25/2014 | 129,050 |
| Richardson Steven Gary | Director | 11/21/2014 | 51,118 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/14/2014 | 1,022,790 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/21/2014 | 2,126,443 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/20/2014 | 1,105,989 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/19/2014 | 2,817,093 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/18/2014 | 2,343,501 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/17/2014 | 941,100 |
| ASELAGE STEVE | Chief Executive Officer | 11/21/2014 | 73,950 |
| ASELAGE STEVE | Chief Executive Officer | 11/20/2014 | 10,660 |
| Golding Cornelius E | Director | 11/19/2014 | 18,000 |
| Plotkin Horacio | Chief Medical Officer | 11/17/2014 | 78,594 |
| Shkreli Martin | Chief Executive Officer | 10/01/2014 | 202,665 |
| Shkreli Martin | Chief Executive Officer | 10/01/2014 | 3,000 |
| Shkreli Martin | Chief Executive Officer | 09/30/2014 | 37,680 |
| Shkreli Martin | Chief Executive Officer | 09/22/2014 | 378,707 |
| Shkreli Martin | Chief Executive Officer | 09/19/2014 | 212,035 |
| Shkreli Martin | Chief Executive Officer | 09/17/2014 | 68,740 |
| Shkreli Martin | Chief Executive Officer | 09/16/2014 | 80,190 |
| Paley Jeffrey | Director | 08/14/2014 | 245,598 |
| Shkreli Martin | Chief Executive Officer | 05/30/2014 | 2,578,793 |
| Shkreli Martin | Chief Executive Officer | 05/30/2014 | 4,426,936 |
| Shkreli Martin | Chief Executive Officer | 04/04/2014 | 157,145 |
| Shkreli Martin | Chief Executive Officer | 04/03/2014 | 508,442 |
| Shkreli Martin | Chief Executive Officer | 04/02/2014 | 240,615 |
| Shkreli Martin | Chief Executive Officer | 03/24/2014 | 70,440 |
| Shkreli Martin | Chief Executive Officer | 03/20/2014 | 89,850 |
| Shkreli Martin | Chief Executive Officer | 03/19/2014 | 64,557 |
| Shkreli Martin | Chief Executive Officer | 03/14/2014 | 69,445 |
| Shkreli Martin | Chief Executive Officer | 03/11/2014 | 504,387 |
| Shkreli Martin | Chief Executive Officer | 03/10/2014 | 206,711 |
| Shkreli Martin | Chief Executive Officer | 03/07/2014 | 45,618 |
| Shkreli Martin | Chief Executive Officer | 03/06/2014 | 29,528 |
| Shkreli Martin | Chief Executive Officer | 03/05/2014 | 73,906 |
| Shkreli Martin | Chief Executive Officer | 02/28/2014 | 802,677 |
| Shkreli Martin | Chief Executive Officer | 02/21/2014 | 1,720 |
| Shkreli Martin | Chief Executive Officer | 02/21/2014 | 28,102 |
| Shkreli Martin | Chief Executive Officer | 02/14/2014 | 51,106 |
| Shkreli Martin | Chief Executive Officer | 02/06/2014 | 19,832 |
| Shkreli Martin | Chief Executive Officer | 01/14/2014 | 86,694 |
| Shkreli Martin | Chief Executive Officer | 09/12/2013 | 25,002 |
| Shkreli Martin | Chief Executive Officer | 12/31/2013 | 1,050,000 |
| Richardson Steven Gary | Director | 08/15/2013 | 4,995 |
| ASELAGE STEVE | Director | 08/15/2013 | 2,502 |
| Golding Cornelius E | Director | 12/24/2013 | 22,500 |
| Shkreli Martin | Chief Executive Officer | 12/09/2013 | 811 |
| Shkreli Martin | Chief Executive Officer | 12/06/2013 | 830 |
| Shkreli Martin | Chief Executive Officer | 11/26/2013 | 1,021 |
| Shkreli Martin | Chief Executive Officer | 11/22/2013 | 1,818 |
| Richardson Steven Gary | Director | 11/05/2013 | 20,010 |
| Shkreli Martin | Chief Executive Officer | 09/12/2013 | 50,004 |
| Plotkin Horacio | Chief Medical Officer | 08/15/2013 | 9,900 |
| Shkreli Martin | Chief Executive Officer | 08/22/2013 | 6,622 |
| Shkreli Martin | Chief Executive Officer | 08/21/2013 | 17,024 |
| PANOFF MARC L | Chief Financial Officer | 08/15/2013 | 4,950 |
| Shkreli Martin | Chief Executive Officer | 03/06/2013 | 425 |
| Shkreli Martin | Chief Executive Officer | 03/11/2013 | 1,880 |
| Shkreli Martin | Chief Executive Officer | 03/04/2013 | 4,425 |
| Shkreli Martin | Chief Executive Officer | 02/20/2013 | 4,662 |
| Shkreli Martin | Chief Executive Officer | 02/14/2013 | 360,000 |
| Shkreli Martin | Chief Executive Officer | 02/12/2013 | 5,000 |
| Shkreli Martin | Chief Executive Officer | 12/26/2012 | 355 |
| Shkreli Martin | Chief Executive Officer | 12/17/2012 | 769 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR RETROPHIN, INC.
STOCK BUYBACKS FOR RETROPHIN, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
0.24%
1Q
06/30/2022
0.59%
2Q
03/31/2022
0.99%
3Q
12/31/2021
6.56%
4Q
09/30/2021
7.64%
5Q
06/30/2021
9.12%
6Q
03/31/2021
13.31%
7Q
12/31/2020
34.12%
8Q
09/30/2020
37.74%
9Q
06/30/2020
45.09%
10Q
Load More